CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?

Background: 3,4-Methylenedioxymethamphetamine intoxication can result in potentially lethal multi-organ failure, for which the current treatment is largely supportive. Recently, a report of the use of the CytoSorb device as a part of the successful treatment of a patient with 3,4-methylenedioxymethamphetamine intoxication and multi-organ failure has been described. Main body: While 3,4-methylenedioxymethamphetamine was very effectively removed by CytoSorb in vitro, the degree of removal in the clinical setting described may have been minimal. Indeed, the therapy was started relatively late in this case, and, as the therapy is concentration dependent, the removal of 3,4-methylenedioxymethamphetamine is likely to have been limited. On the other hand, in this case, CytoSorb hemoadsorption was very effective to treat rhabdomyolysis and hyperinflammation. Conclusion: The in vitro experimentation demonstrates that 3,4-methylenedioxymethamphetamine is effectively removed by CytoSorb. However, it is debatable whether the case report confirms the possibility of in vivo removal of 3,4-methylenedioxymethamphetamine by CytoSorb. Nevertheless, the potential of the CytoSorb device to contribute to the treatment of many critically ill patients has yet to be fully explored, and further studies are warranted.SCOPUS: no.jinfo:eu-repo/semantics/publishe

Reliability of biomarkers of sepsis during extracorporeal therapies: The clinician needs to know what is eliminated and what is not

SCOPUS: re.jinfo:eu-repo/semantics/publishe

Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?

SCOPUS: ed.jinfo:eu-repo/semantics/publishe

Improve short-term survival in postcardiotomy cardiogenic shock by simultaneous use of intra-aortic balloon pumping with veno-arterial extracorporeal membrane oxygenation: Beware of confounders!

SCOPUS: le.jinfo:eu-repo/semantics/publishe

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?

SCOPUS: ed.jinfo:eu-repo/semantics/publishe

The challenge of removal of sepsis markers by continuous hemofiltration

SCOPUS: le.jinfo:eu-repo/semantics/publishe

Lack of relationship between fasting plasma citrulline and glucose absorption: Do not underestimate the role of the failing kidney!

SCOPUS: le.jinfo:eu-repo/semantics/publishe

Mechanism of arrhythmias during the infusion of Ringer's acetate and Ringer's lactate solutions during cardiac surgery: New insights

SCOPUS: le.jinfo:eu-repo/semantics/publishe

ECMO in paediatric septic shock: An urgent need for prospective trial

SCOPUS: le.jinfo:eu-repo/semantics/publishe

Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: The jury is still out

SCOPUS: le.jinfo:eu-repo/semantics/publishe